DemocratBill · H.R. 124· House(119-HR-124)

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

Rep. Green
Age: 79 years
Texas
Introduced
1/3/2025
Last activity
1/3/2025 — Referred to the House Committee on Energy and Commerce.
Sponsored by
Al Green
Cosponsors
None
Health
  1. Introduced
  2. In Committee

What this bill would do

This bill, known as the ``Byron Nash Renal Medullary Carcinoma Awareness Act of 2023'', aims to amend title XIX of the Social Security Act. The purpose is to provide incentives for education regarding the risk of renal medullary carcinoma. This focus is specifically for individuals receiving medical assistance under that title who also have sickle cell disease. The changes would apply to items and services furnished on or after the date the Act is enacted.

Yes· 3 of 4

  • Would Black Americans be better off under this?+3

    The bill targets education for individuals with sickle cell disease, a condition that disproportionately affects African Americans.

  • Would households on low incomes be better off under this?+2

    The bill benefits Medicaid recipients through increased education on renal medullary carcinoma risks.

  • Does this put more money into Medicaid, the health coverage for people on low incomes?+2

    The bill incentivizes education for individuals receiving medical assistance under Medicaid regarding renal medullary carcinoma.

The opposite

No question was scored the opposite.